Pediatric Psychopharmacotherapy Flashcards
1
Q
What is the first line therapy for pediatric ADHD?
A
Methylphenidate
* Avoid IR productive - diversion risks
2
Q
Concerta
A
- Take in the morning
- AUC stimulates TID dosing regimen
- Tablets intact in stool
3
Q
Transdermal MPH-Daytrana
A
- ADHD
- Apply 2 hours before expected effects
- Mild skin reactions, bleaching, tics, anorexia, and insomnia
4
Q
Quillivant ER
A
- ADHD
- Vigorously shake bottle for at least 10 seconds
- May be taken with or without food
- Drug errors by pharmaceutics in reconstitution
5
Q
Azstarys
A
- 70% Serdexmethylphenidate (prodrug for d-methylphenidate) and 30% of IR d-methylphenidate
- Daily dosing in the morning with or without food
- For ADHD
6
Q
Transdermal Dextroamphetamine - Xelstrym
A
- ADHD in patients >= 6 years old
- Application site reactions
- Apply 2 hours before effect needed
7
Q
Lisdexamfetamine (Vvyanse)
A
- May reduce the risk of diversion, abuse
- Approved for binge-eating disorder and ADHD
8
Q
What is the preferred medication for ADHD in toddlers?
A
- Behavioral Therapy and Parent Training Preferred with medication ONLY after 8-12 weeks-moderate to severe disability
- Methylphenidate if needed
- can exacerbate mood liability so they could go quickly into extreme irritabiltiy in 2-6 year olds
9
Q
What medication to give for side effects of stimulants?
A
- Atomoxetine
10
Q
What are some nonstimulant options for ADHD?
A
- Atomoxetine
- Viloxazine (Qelbree)
- Clonidine
- Guanfacine
11
Q
What are some adverse effects of atomoxetine?
A
- Emesis
- Nausea
- Dyspepsia
- Increased risk of suicidal ideation in children
- Urinary retention
- Priapism
- Sudden death, stroke, MI
12
Q
Viloxazine (Qelbree)
A
- ADHD
- Norepinephrine reuptake inhibitor and serotonin mediator
13
Q
What are some adverse effects of Viloxazine (Qelbree)?
A
- Somnolence, fatigue, decreased appetite
- Increases HR
- Risk of suicidal thoughts and suicidal ideation
14
Q
How has pediatric psychotropic changed?
A
- Medication creep (expanded drug classes without research)
- Poly pharmacy more common
- Diagnosis and treatment in the very young
- Increased drug use in autism and intellectual disability
- Health disparities in evaluation